Poland (PL)

Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study (2018) Corsonello A, Tap L, Roller-Wirnsberger R, Wirnsberger G, Zoccali C, Kostka T, Guligowska A, et al. Journal article Amino-Terminal Processing of Helicobacter pylori Serine Protease HtrA: Role in Oligomerization and Activity Regulation (2018) Albrecht N, Tegtmeyer N, Sticht H, Skorko-Glonek J, Backert S Journal article Structural characterization and evaluation of antibacterial and angiogenic potential of gallium-containing melt-derived and gel-derived glasses from CaO-SiO2 system (2018) Wajda A, Goldmann W, Detsch R, Grünewald A, Boccaccini AR, Sitarz M Journal article, Original article Novel injectable gellan gum hydrogel composites incorporating Zn- and Sr-enriched bioactive glass microparticles: High-resolution X-ray microcomputed tomography, antibacterial and in vitro testing (2018) Douglas TEL, Dziadek M, Gorodzha S, Liskova J, Brackman G, Vanhoorne V, Vervaet C, et al. Journal article, Original article rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al. Journal article Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis (2018) Konturek P, Zopf Y, Dieterich W, Wirtz S, Neurath M, Brzozowski T Conference contribution Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study (2018) Crona J, Lamarca A, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Vidal Trueba H, et al. Conference contribution Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? (2018) Merola E, Zandee W, De Mestier L, Klumpen HJ, Geboes KP, Poczkaj K, W DH, Munir A Conference contribution Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension (2018) Pavel ME, Cwikla J, Wolin E, Phan A, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study (2018) Wolin EM, Pavel ME, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution